[4] Tempus uses data and artificial intelligence (AI) to create precision medicine services, including diagnostics,[5] for oncology, cardiology, radiology, and depression.
[9] It is headquartered in Chicago, and has offices in New York City, the San Francisco Bay Area, Boston, Washington, D.C., Seattle, Milwaukee, Lewisburg, PA, Calgary, and Barcelona, plus three CAP/CLIA labs in Chicago, the Atlanta area (Peachtree Corners), and Research Triangle Park.
[10][11] Tempus investors include SoftBank Group, Baillie Gifford, New Enterprise Associates, Novo Holdings, Franklin Templeton Investments, T. Rowe Price, Revolution LLC, Google LLC, and others.
[12] In June 2024, Tempus and SoftBank formed an AI healthcare joint venture in Japan called SB Tempus with a plan to develop personalized treatment recommendations by analyzing medical data with AI.
[15] The company's advisory board includes Jennifer Doudna and Scott Gottlieb.